Congratulations to Site 2425 – United States – MacCumber on being named the Galaxy World Cup Champion!
🏆Congratulations to Site 2425 – United States – MacCumber on being named the Galaxy World Cup Champion!
Following six weeks of competition, collaboration, and dedicated recruitment efforts, we are proud to celebrate this outstanding achievement in the ONL1204-GA-002 Galaxy World Cup. This is a Phase 2 trial investigating Xelafaslatide for geographic atrophy (GA) in dry AMD developed by ONL Therapeutics.
Site 2425 (our own research team lead by Professor Mathew MacCumber, MD, PhD), achieved first place among participating sites worldwide. Through exceptional performance, consistency, and commitment to patient recruitment and enrollment.
We extend our sincere congratulations to the entire team for this remarkable accomplishment and thank everyone whose dedication and teamwork contributed to the success of the tournament and the continued advancement of the study.
Congratulations on this well-deserved achievement! 👏
